About NeuroPoint Dx
NeuroPoint Dx is a company based in Madison (United States) founded in 2006. NeuroPoint Dx offers products and services including NPDX ASD Blood Test and Research Publications. NeuroPoint Dx operates in a competitive market with competitors including Lineagen, Linus Biotechnology, MARAbio, Pediatric Bioscience and SensOmics, among others.
- Headquarter Madison, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NeuroPoint Dx
NeuroPoint Dx offers a comprehensive portfolio of products and services, including NPDX ASD Blood Test and Research Publications.
Blood test for early autism detection and metabolic subtype analysis.
Scientific papers on autism metabolism and treatment insights.
People of NeuroPoint Dx
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of NeuroPoint Dx
Detailed funding history for NeuroPoint Dx
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NeuroPoint Dx
Investment portfolio details for NeuroPoint Dx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NeuroPoint Dx
Detailed financials for NeuroPoint Dx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neuropoint Dx Comparisons
Peer comparison for NeuroPoint Dx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NeuroPoint Dx
NeuroPoint Dx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lineagen, Linus Biotechnology, MARAbio, Pediatric Bioscience and SensOmics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sequencing-based diagnostic tests and services for autism are provided.
|
|
| Locked | Locked | Locked |
Developer of diagnostic tests for central nervous system and gastrointestinal disorders
|
|
| Locked | Locked | Locked |
A blood test for maternal autoantibody-related autism is developed.
|
|
| Locked | Locked | Locked |
Provides blood biomarker-based diagnostics for autism spectrum disorders.
|
|
| Locked | Locked | Locked |
Precision medicine for children's health is provided through genomic integration.
|
Detailed competitors of NeuroPoint Dx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neuropoint Dx
Complete news archive for NeuroPoint Dx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuroPoint Dx
NeuroPoint Dx was founded in 2006.
NeuroPoint Dx is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
NeuroPoint Dx develops diagnostic tests using metabolomics for neuro-developmental disorders. It uses the metabolomics platform, as developed by parent company Stemina Biomarker Discovery, to diagnose and prescribe best treatments for neurological disorders. First application is autism-spectrum disorders.
NeuroPoint Dx's top competitors include Linus Biotechnology, MARAbio and Lineagen.
NeuroPoint Dx offers NPDX ASD Blood Test and Research Publications.